EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Analytical Biomarkers for Inflammation Status Monitoring of Psychotropic and Antiepileptic Drugs

Wiktoria Jiers, Karina Sommerfeld-Klatta, Mehmet Gumustas iD, Paul Mozdziak iD, Magdalena Łukasik-Głębocka, Artur Teżyk iD, Zbigniew Żaba, Czesław Żaba, Hanna Piotrowska-Kempisty

Pharmaceuticals · 17.08.2025 · 18 (8) · 1213

DOI: 10.3390/ph18081213 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 17.08.2025. Verfasst von Wiktoria Jiers und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology, Poznań University of Medical Sciences, 3 Rokietnicka Street, 60-631 Poznań, Poland. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: USDA NIFA Animal Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, an increasing amount of research has investigated the impact of chronic inflammation on the development and progression of both neurological and psychiatric disorders, including epilepsy, depression, schizophrenia, and bipolar disorder. Moreover, growing attention is being paid to how inflammatory processes contribute to disease mechanisms, influence symptom severity, and interact with pharmacological treatments in these conditions. Changes in the levels of inflammatory biomarkers, such as cytokines and C-reactive protein, may signal the early stages of neurological disorder development. Furthermore, specific biomarker profiles have been identified for individual diseases, and chronic treatment may affect their blood levels. Over the last two decades, significant progress in the study of inflammatory biomarkers in psychiatric disorders and epilepsy has been achieved, demonstrating an association between biomarkers with symptoms, a potential prognostic role, and possible use in personalising therapy. Furthermore, widely used methods for biomarker evaluation, such as immunoenzymatic assays and flow cytometry, remain essential tools for current research. Despite numerous indications of the importance of inflammation in psychiatry and neurology, the available studies are characterised by considerable heterogeneity in terms of both population selection and methodology. Based on the available data, inflammatory biomarkers represent a promising diagnostic and therapeutic tool for epilepsy and psychiatric disorders. Although existing studies suggest a correlation between inflammation and the symptoms of various disorders, inconsistent results highlight the need for further research to enable wider implementation of these findings in psychiatric and epilepsy practice. Advancing knowledge of inflammatory biomarkers is essential for improving treatment outcomes and promoting the development of targeted interventions.

Schlagwörter

Stichwörter der Autor:innen

anti-inflammatory treatmentbiomarkersinflammationpsychotropic and antiepileptic drugs

Autor:innen und Institutionen

  • Department of Toxicology, Poznań University of Medical Sciences, 3 Rokietnicka Street, 60-631 Poznań, Poland.
  • Doctoral School, Poznań University of Medical Sciences, 70 Bukowska Street, 60-812 Poznań, Poland.
  • Institute of Forensic Sciences, Department of Forensic Toxicology, Ankara University, Balkiraz, Mamak Cd.6 A, Mamak, Ankara 06620, Turkey.
  • Prestige Department of Poultry Science, College of Agriculture and Life Sciences, North Carolina State University, Raleigh, NC 27695, USA.
  • Department of Emergency Medicine, Poznań University of Medical Sciences, 7 Rokietnicka Street, 60-806 Poznań, Poland.
  • Department of Forensic Medicine, Poznań University of Medical Sciences, 10 Rokietnicka Street, 60-806 Poznań, Poland.

ORCID-Profile: Mehmet Gumustas, Paul Mozdziak, Artur Teżyk

Förderung

  • USDA NIFA Animal Health

Zitieren

APA

Jiers, W., Sommerfeld-Klatta, K., Gumustas, M., Mozdziak, P., Łukasik-Głębocka, M., Teżyk, A., Żaba, Z., Żaba, C., & Piotrowska-Kempisty, H. (2025). Analytical Biomarkers for Inflammation Status Monitoring of Psychotropic and Antiepileptic Drugs. Pharmaceuticals, 18(8), 1213. https://doi.org/10.3390/ph18081213

Vancouver

Jiers W, Sommerfeld-Klatta K, Gumustas M, Mozdziak P, Łukasik-Głębocka M, Teżyk A, et al. Analytical Biomarkers for Inflammation Status Monitoring of Psychotropic and Antiepileptic Drugs. Pharmaceuticals. 2025;18(8):1213. doi:10.3390/ph18081213

BibTeX
@article{Jiers2025,
  author = {Jiers, Wiktoria and Sommerfeld-Klatta, Karina and Gumustas, Mehmet and Mozdziak, Paul and Łukasik-Głębocka, Magdalena and Teżyk, Artur and Żaba, Zbigniew and Żaba, Czesław and Piotrowska-Kempisty, Hanna},
  title = {Analytical Biomarkers for Inflammation Status Monitoring of Psychotropic and Antiepileptic Drugs},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {8},
  pages = {1213},
  doi = {10.3390/ph18081213}
}
Kostenlos starten →